Chester County News and Community Website
FORT WASHINGTON, PA — CCA Industries, Inc. (OTC: CAWW) has disclosed its financial outcomes for the first quarter ending February 29, 2024, revealing a net loss of $245,410, an improvement …
CCA Industries Reports Narrowed Losses and Announces Nationwide Launch of Neutein at CVS Read More
PHILADELPHIA, PA — Carisma Therapeutics Inc. (NASDAQ: CARM) recently disclosed its financial results for the fourth quarter and the full year concluding on December 31, 2023, outlining a plan to …
Carisma Therapeutics Concentrates on Promising CT-0525, Restructures to Manage Finances amid 2023 Losses Read More
RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a biopharmaceutical company focused on the development of innovative therapies for complex medical conditions, recently unveiled its financial outcomes for the quarter …
NRx Pharmaceuticals Charts New Path with Strategic Milestones and Cost Reductions Read More
WILMINGTON, DE — Onfolio Holdings Inc. (NASDAQ: ONFO, ONFOW), a growing player in the B2B marketing services sector, recently released their fourth quarter and full year earnings for 2023, providing …
Onfolio Holdings Inc. Charts Path to Profitability Amid Market Headwinds Read More
MALVERN, PA — In a recent financial report for 2023, Annovis Bio, Inc. (NYSE: ANVS) proclaimed progress in the battle against neurodegenerative diseases; however, the path to potential breakthroughs has …
Annovis Bio Makes Strides in Neurodegenerative Disease Treatment: 2023 Q4 Results Below Projections, Progress Seen in Clinical Trials Read More
LANGHORNE, PA — Nexgel Inc (NASDAQ: NXGL), a leading corporation in the health and wellness industry, reported an impressive rise in revenue for their fourth quarter and annual performance of …
NEXGEL’s Engineered Growth: A Triumph in Operational Efficiency and Strategic Partnerships Read More
CHESTERBROOK, PA — Trevena, Inc. (Nasdaq: TRVN), a leading pharmaceutical company, has recently unveiled its financial outcomes for the closing quarter of 2023, amidst a pivotal shift in their corporate …
Trevena Ramps Up Efforts on TRV045, Turns Attention Away from OLINVYK Amid Challenging Hospital Environment Read More
BERWYN, PA — Recent developments have been flourishing for Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX). The Pennsylvania-based pharmaceutical innovator recently unveiled its financial records for 2023 and shared a series of …
Virpax Pharmaceuticals Set for Transformative Year with High Hopes for Non-Addictive Pain Management Solutions Read More
NEWTOWN, PA — In a market landscape dominated by titans in the biotech and healthcare technology sectors, Helius Medical Technologies, Inc. (Nasdaq: HSDT) found themselves in a David versus Goliath …
Helius Medical Technologies: Strides Towards Reimbursement for Innovative PoNS Therapy Amidst Financial Challenges Read More
NEWTOWN SQUARE, PA — In recent developments from the pharmaceutical industry, ArriVent BioPharma Inc. (Nasdaq: AVBP), a notable player in the arena of breakthrough cancer therapy, has seen a transformative …
ArriVent BioPharma Unveils Promising Developments and Strong Financial Performance in 2023 Read More